The 51 references in paper T. Stehlé ., D. Joly ., Ph. Vanhille ., J. Boffa -J., Ph. Rémy ., L. Mesnard ., M. Hoffmann ., Ph. Grimbert ., G. Choukroun ., F. Vrtovsnik ., J. Verine ., D. Desvaux ., F. Walker ., Ph. Lang ., M. Mahevas ., D. Sahali ., V. Audard ., Т. Стелье ., Д. Джоли ., Ф. Ванилл ., Ж. Боффа -Ж., Ф. Реми ., Л. Меснар ., М. Хоффман ., Ф. Гримбер ., Г. Шукру ., Ф. Вртовсник ., ДЖ. Верин ., Д. Десво ., Ф. Волкер ., Ф. Ланг ., М. Махевас ., Д. Сахали ., В. Одар . (2014) “Клинико-патологическое многоцентровое исследование гломерулопатий, ассоциированных с саркоидозом // Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study” / spz:neicon:nefr:y:2014:i:1:p:14-24

1
Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet
(check this in PDF content)
2
03; 361 (9363): 1111–1118 2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Eng J Med 2007; 357 (21): 2153–2165
(check this in PDF content)
3
Baughman RP, Teirstein AS, Judson MA et al. Case Control Etiologic Study of Sarcoidosis research g: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1885–1889
(check this in PDF content)
4
Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Eng J Med 1981; 305 (8): 429–434
(check this in PDF content)
5
Nunes H, Bouvry D, Soler P, Valeyre D. Sarcoidosis. Orphanet J Rare Dis 2007; 2: 46
(check this in PDF content)
6
Berliner AR, Haas M, Choi MJ. Sarcoidosis: the nephrologist’s perspective.Am J Kidney Dis 2006; 48 (5): 856–870
(check this in PDF content)
7
Gobel U, Kettritz R, Schneider W, Luft F. The protean face of renal sarcoidosis. JASN 2001; 12 (3): 616–623
(check this in PDF content)
8
Mahevas M, Lescure FX, Boffa JJ et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009; 88 (2): 98–106
(check this in PDF content)
9
Rajakariar R, Sharples EJ, Raftery MJ, et al. Sarcoid tubulointerstitial nephritis: long-term outcome and response to corticosteroid therapy. Kidney Int 2006; 70 (1): 165–169
(check this in PDF content)
10
Taylor RG, Fisher C, Hoffbrand BI. Sarcoidosis and membranous glomerulonephritis: a significant association. Br Med J (Clin Res Ed) 1982; 284 (6325): 1297–1298
(check this in PDF content)
11
Oliver Rotellar JA, Garcia Ruiz C, Martinez Vea A. Response to prednisone in membranous nephropathy associated with sarcoidosis. Nephron 1990; 54 (2): 195
(check this in PDF content)
12
Toda T, Kimoto S, Nishio Y et al. Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis. Intern Med 1999; 38 (11): 882–886
(check this in PDF content)
13
Kaaroud H, Fatma LB, Beji S et al. Interstitial and glomerular renal involvement in sarcoidosis. Saudi J Kidney Dis Transpl 2008; 19 (1): 67–71
(check this in PDF content)
14
Knehtl M, Debiec H, Kamgang P et al. A case of phospholipase A(2) receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 2011; 57 (1): 140–143
(check this in PDF content)
15
Parry RG, Falk C. Minimal-change disease in association with sarcoidosis. Nephrol, Dial, Transplant 1997; 12 (10): 2159– 2160 Mundlein E, Greten T, Ritz E. Graves’ disease and sarcoidosis in a patient with minimal-change glomerulonephritis. Nephrol, Dial, Transplant 1996; 11 (5): 860–862
(check this in PDF content)
16
Nishimoto A, Tomiyoshi Y, Sakemi T et al. Simultaneous occurrence of minimal change glomerular disease, sarcoidosis and Hashimoto’s thyroiditis. Am J Nephrol 2000; 20 (5): 425–428
(check this in PDF content)
17
Lee SM, Michael AF. Focal glomerular sclerosis and sarcoidosis. Arch PatholLab Med 1978; 102 (11): 572–575
(check this in PDF content)
18
Veronese FJ, Henn Lde A, Faccin CS et al. Pulmonary sarcoidosis and focal segmental glomerulosclerosis: case report and renal transplant follow-up. Nephrol, Dial, Transplant 1998; 13 (2): 493–495
(check this in PDF content)
19
Peces R, de la Torre M, Sanchez-Fructuoso A, Escalada P. Focal segmental glomerulosclerosis associated with pulmonary sarcoidosis. Nephron 1993; 65 (4): 656–657
(check this in PDF content)
20
Murray FE, Lombard MG, Donohoe JF et al. Simultaneous presentation of IgA nephropathy and sarcoidosis. Sarcoidosis 1987; 4 (2): 134–136
(check this in PDF content)
21
Chung-Park M, Lam M, Yazdy AM. IgA nephropathy associated with sarcoidosis. Am J Kidney Dis 1990; 15 (6): 601–602
(check this in PDF content)
22
Tateno S, Kobayashi Y, Kobayashi F: A case of sarcoidosis revealed in the course of IgA nephropathy. Pathol Int 1994; 44 (5): 387–390
(check this in PDF content)
23
Taylor JE, Ansell ID. Steroid-sensitive nephrotic syndrome and renal impairment in a patient with sarcoidosis and IgA nephropathy. Nephrol, Dial, Transplant 1996; 11 (2): 355–356
(check this in PDF content)
24
Howard RS, Gabriel R: Glomerulonephritis in sarcoidosis: causal relationship unproven. Postgrad Med J 1992; 68 (797): 206–208
(check this in PDF content)
25
Hagiwara S, Ohi H, Eishi Y et al. A case of renal sarcoidosis with complement activation via the lectin pathway. Am J Kidney Dis 2005; 45 (3): 580–587
(check this in PDF content)
26
Stehlй et al. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) Orphanet J Rare Dis 2013; 8 (65): 9 -10
(check this in PDF content)
27
Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J 1961; 2 (5261): 1165–1172
(check this in PDF content)
28
Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67 (6): 2089–2100
(check this in PDF content)
29
Audard V, Larousserie F, Grimbert P et al. Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int 2006; 69 (12): 2251–2260
(check this in PDF content)
30
D‘Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43 (2): 368–382
(check this in PDF content)
31
Glassock RJ. Human idiopathic membranous nephropathy–a mystery solved? N Eng J Med 2009; 361 (1): 81–83
(check this in PDF content)
32
Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76 (5): 534–545
(check this in PDF content)
33
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40 (9):1725
(check this in PDF content)
34
Weening JJ, D’Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. JASN 2004; 15 (2): 241–250
(check this in PDF content)
35
Schena FP. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrol, Dial, Transplant 1997; 12 (3): 418–426
(check this in PDF content)
36
Swaminathan S, Leung N, Lager DJ et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. CJASN 2006; 1 (3): 483–487
(check this in PDF content)
37
Konishi K, Moller DR, Saltini C et al. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest 1988; 82 (3): 775–781
(check this in PDF content)
38
Bargagli E, Mazzi A, Rottoli P. Markers of inflammation in sarcoidosis:blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 2008;29 (3): 445–458
(check this in PDF content)
39
Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203 (2): 359–370
(check this in PDF content)
40
Zhang S, Audard V, Fan Q et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol 2011; 169: 94–106
(check this in PDF content)
41
Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 2000; 12 (1): 71–76
(check this in PDF content)
42
Laflam PF, Garin EH. Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr Nephrol 2006; 21 (2): 177–181
(check this in PDF content)
43
Noel LH, Zanetti M, Droz D et al. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 1979; 66 (1): 82–90
(check this in PDF content)
44
Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Eng J Med 1993; 329 (2): 85–89
(check this in PDF content)
45
Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48 (5): 1600–1604
(check this in PDF content)
46
Jha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. JASN 2007;18 (6): 1899–1904
(check this in PDF content)
47
Barratt J, Smith AC, Molyneux K, Feehally J. Immunopathogenesis of IgAN.Semin Immunopathol 2007; 29 (4): 427–443
(check this in PDF content)
48
Wesemann DR, Costenbader KH, Coblyn JS. Co-existing sarcoidosis, systemic lupus erythematosus and the antiphospholipid antibody syndrome: case reports and discussion from the Brigham and Women’sHospital Lupus Center. Lupus 2009; 18 (3): 202–205
(check this in PDF content)
49
Rajoriya N, Wotton CJ, Yeates DG et al. Immunemediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J 2009;85 (1003): 233–237
(check this in PDF content)
50
Weinberg I, Vasiliev L, Gotsman I. Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum 2000; 29 (5): 328–331
(check this in PDF content)
51
Nishiki M, Murakami Y, Yamane Y, Kato Y. Steroid-sensitive nephrotic syndrome, sarcoidosis and thyroiditis–a new syndrome? Nephrol, Dial, Transplant 1999; 14 (8): 2008–2010 Перевод: Муравьев Н.Г Редакция перевода: Трофименко И.И.
(check this in PDF content)